Health Care Select Sector SPDR Fund (XLV) carries a Roarable Rating of C (Hold) with 64/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Health Care Select Sector SPDR Fund (XLV) advanced +0.45% to $184.87 as options desks priced 57% call premium vs. 43% put protection around the $185 max-pain magnet. Solid 58% profit margin (20% return on capital), mixed timing at 22x P/E—hold if owned, no rush to chase.
Stocks have been shaky as technology takes a hit, but the Fed's latest move to hold rates steady signals that policymakers will support the markets if the going gets tough.
The health insurer’s third-quarter results helped reinforce the stock’s momentum.
Alphabet logs its worst week since 2011 and Intel its worst day ever as the AI trade cracks, while health care posts a record month against the market.
Two health care ETFs track the same sector but own very different slices of it, and for retirees building a portfolio, that gap in biotech exposure and concentration could matter more than the nearly identical returns su
Regeneron's blockbuster earnings sent its stock soaring, but the real story is how that move ripples through the health care ETFs sitting inside millions of retirement accounts, and whether fund holders are more exposed
Intel nears its worst day on record after weak guidance, sinking chip stocks as SMH falls 7.0% and the Nasdaq 100 drops 3.2%.
Five sectors are higher and six are lower in Friday's regular session, with defensive sectors holding the top three positions. The leaders are clustered rather than separated, while Technology sits well clear of the
U.S. stock markets closed lower on Thursday terminating a three-day winning run.
Alphabet and Microsoft both missed AI capex expectations for Q3 - this bursts the AI infrastructure bubble. Read more on what the bubble burst looks like.
IWD is beating SPY by 4.2 points in October, the widest monthly gap since 2001; Alphabet and ServiceNow lead a rotation away from AI.
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +9.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on XLV today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for XLV. Explore sector supply chains on /butterfly.
Why XLV Stock advanced +0.45% Today — RQD Quant Desk Flash. Solid 58% profit margin (20% return on capital), mixed timing at 22x P/E—hold if owned, no rush to chase.